Increasing Activity in Liver Transplant Patients
Launched by MAYO CLINIC · Feb 6, 2014
Trial Information
Current as of May 12, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • Adult patients 18-65 years of age who receive a liver transplant at Mayo Clinic Jacksonville.
- • Adult patients who are 5-21 days post liver transplant.
- • Must be followed by Mayo Clinic Jacksonville at 4 months postoperatively.
- • Approved by a hepatologist and/or transplant surgeon to participate.
- Exclusion criteria:
- • Patients with active infections
- • Patients with encephalopathy or cognitive dysfunction
- • Patients who receive a combined liver-kidney transplant
- • Patients with severe debility
- • Patients who require assistance to ambulate.
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jacksonville, Florida, United States
Patients applied
Trial Officials
Jennifer Serotta, ARNP
Principal Investigator
Mayo Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials